thiotepa has been researched along with Abnormalities, Autosome in 85 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Excerpt | Relevance | Reference |
---|---|---|
"From June 1997 to November 1999, 28 SRCT patients (median age, 26 years; 14 peripheral primitive neuroectodermal tumors [pPNETs], seven rhabdomyosarcomas [RMSs], and seven desmoplastic small round-cell tumors [DSRCTs]) received induction chemotherapy with ifosfamide, epirubicin, and vincristine followed by HD-CT." | 5.10 | High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study. ( Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H, 2002) |
"Chromosomal aberrations were quantitated using traditional Giemsa stain." | 1.33 | The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. ( Balis, F; Bates, S; Cole, D; Egorin, MJ; Flynn, BM; Fojo, T; Knutsen, T; Langham, G; Rao, VK; Ried, T; Steinberg, SM; Wangsa, D, 2005) |
"It was observed, that the rate of chromosome aberrations and SCE increased within a matter of first 6 hours." | 1.27 | [Changes in the occurrence of cytogenetic effects after mutagenic exposure in vivo]. ( Chebotarev, AN; Stukalov, SV, 1983) |
"Caffeine was found to potentiate the frequency of chromatid aberrations induced by all 3 S-dependent agents tested; the most striking enhancement being obtained when caffeine was present during the last 1." | 1.27 | Influence of caffeine and 3-aminobenzamide in G2 on the frequency of chromosomal aberrations induced by thiotepa, mitomycin C and N-methyl-N-nitro-N'-nitrosoguanidine in human lymphocytes. ( Hansson, K; Kihlman, BA; Palitti, F; Tanzarella, C, 1984) |
"Styrene oxide proved also to be a very potent inducer of sister chromatid exchanges (SCE) within the concentration range 5 X 10(-6) to 1 X 10(-3) mol." | 1.27 | Cytogenetic analysis of human peripheral blood lymphocytes in culture exposed in vitro to styrene and styrene oxide. ( Pohlová, H; Rössner, P; Srám, RJ, 1984) |
" It was shown that the dose-response relationships and corresponding regression coefficients were similar when the in vivo and in vitro results were compared." | 1.27 | [Quantitative comparison of the cytogenetic effect of thiophosphamide during in vivo and in vitro action on monkey lymphocytes]. ( Kuzin, SM; Popandopulo, PG; Stukalov, SV, 1987) |
"The frequency of chromosome aberrations in the initial period somewhat increases and then keeps to a certain constant level independently on the duration of action of thiophosphamide." | 1.26 | [Effect of long-term exposure to thiophosphamide on the frequency of chromosome aberrations in Chinese hamster cell cultures]. ( Chebotarev, AN; Ressner, P; Selezneva, TG, 1980) |
"Chromosome aberrations were studied in cells of embryo liver of 101/H and CBA mice following mutagenic treatment with the alkylating agent--thiophosphamide." | 1.26 | [101/H line mice, a possible model of human chromosomal instability diseases]. ( Korogodina, IuV; S'iakste, TG, 1981) |
"In C57BL/6 mice the level of induced chromosome aberrations was found to be age-independent." | 1.26 | [Spontaneous and induced chromosome aberrations in the bone marrow cells of different strains of mice during aging]. ( Korogodina, IuV; Lil'p, IG, 1981) |
"Chromosomal aberrations were studied in cells of embryonic liver and bone marrow of A/He and C57BL/6 mice following mutagenic treatment by the alkylating agent thiophosphamide in g1-S periods of the cell cycle." | 1.26 | [Thiophosphamide-induced chromosome aberrations in embryonal liver and bone marrow cells of A/He and C57BL/L mice]. ( Gordeeva, EV; Korogodina, IuV; Lil'p, IG, 1979) |
"Griseofulvin was studied for its ability to induce structural chromosomal aberrations in germ and somatic cells of the male mouse." | 1.26 | Mutagenicity tests with griseofulvin. ( Carbonelle, E; Fabry, L; Grutman, G; Léonard, A; Poncelet, F, 1979) |
"The contribution of induced chromosomal aberrations to preimplantation embryonic death was studied." | 1.26 | [Estimation of the contribution of thiophosphamide-induced chromosomal aberrations to perimplantation embryonic mortality in mice]. ( Malashenko, AM; Semenov, KhKh, 1979) |
"Types of chromosome aberrations were studied in human lymphocyte cultures in combined action of different concentrations of thiophosphamide and dipine in different proportions." | 1.26 | [Analysis of the types of chromosome aberrations in the combined action of chemical mutagens]. ( Nazarenko, SA, 1978) |
"Structure chromosome aberrations were found in the cells of such embryos." | 1.26 | [Mutagenic effect of chemical compounds on laboratory mice]. ( Malashenko, AM; Selezneva, GP; Semenov, KhKh; Surkova, NI, 1978) |
"ThioTEPA was injected intraperitoneally once a week in a dose of 40 mg." | 1.25 | [Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans]. ( Aĭnbinder, NM; Gnilevskaia, ZU; Neĭshtadt, EL, 1975) |
"The rate of induced chromosome aberrations was correlated with the level of spontaneous chromosome damages in bone marrow cells (r=+/-0,893+/-0,02)." | 1.25 | [The mutagenic effect of thioTEPA in laboratory mice. IV. The influence of genotype and sex on the frequency of induced chromosome aberrations in bone marrow cells]. ( Malashenko, AM; Surkova, NI, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 74 (87.06) | 18.7374 |
1990's | 7 (8.24) | 18.2507 |
2000's | 3 (3.53) | 29.6817 |
2010's | 1 (1.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riethdorf, S | 1 |
Pantel, K | 1 |
MOORE, JG | 1 |
VANCAMPENHOUT, JL | 1 |
BRANDKAMP, WW | 1 |
Rao, VK | 1 |
Knutsen, T | 1 |
Ried, T | 1 |
Wangsa, D | 1 |
Flynn, BM | 1 |
Langham, G | 1 |
Egorin, MJ | 1 |
Cole, D | 1 |
Balis, F | 1 |
Steinberg, SM | 1 |
Bates, S | 1 |
Fojo, T | 1 |
Hansson, K | 3 |
Hartley-Asp, B | 2 |
Murphy, WM | 1 |
Stukalov, SV | 6 |
Chebotarev, AN | 9 |
Shcheglova, EG | 2 |
Kihlman, BA | 2 |
Tanzarella, C | 1 |
Palitti, F | 1 |
Pohlová, H | 1 |
Rössner, P | 1 |
Srám, RJ | 2 |
Ivanova, IuE | 1 |
Bochkov, NP | 8 |
Iakovenko, KN | 4 |
Ressner, P | 1 |
Selezneva, TG | 2 |
Devi, KR | 1 |
Reddy, PP | 1 |
Korogodina, IuV | 3 |
S'iakste, TG | 1 |
Lil'p, IG | 2 |
Malashenko, AM | 15 |
Kryshkina, VP | 1 |
Surkova, NI | 8 |
Yakovenko, KN | 3 |
Voskoboiynik, NI | 1 |
Beskova, TB | 3 |
Salikhova, RA | 1 |
Poroshenko, GG | 1 |
Goncharova, RI | 1 |
Kuzhir, TD | 1 |
Dalivelia, OV | 1 |
Dubur, GIa | 1 |
Uldrikis, IaR | 1 |
Ignat'eva, EL | 1 |
Bertuzzi, A | 1 |
Castagna, L | 1 |
Nozza, A | 1 |
Quagliuolo, V | 1 |
Siracusano, L | 1 |
Balzarotti, M | 1 |
Compasso, S | 1 |
Alloisio, M | 1 |
Soto Parra, H | 1 |
Santoro, A | 1 |
Maier, P | 1 |
Schmid, W | 1 |
Littlefield, LG | 1 |
Colyer, SP | 1 |
Sayer, AM | 1 |
Dufrain, RJ | 1 |
Gordeeva, EV | 1 |
Léonard, A | 1 |
Poncelet, F | 1 |
Grutman, G | 1 |
Carbonelle, E | 1 |
Fabry, L | 1 |
Semenov, KhKh | 3 |
Wolff, S | 1 |
Arutyunyan, R | 1 |
Sturelid, S | 2 |
Nazarenko, SA | 1 |
Selezneva, GP | 1 |
Neĭshtadt, EL | 1 |
Gnilevskaia, ZU | 1 |
Aĭnbinder, NM | 1 |
Kirichenko, OP | 1 |
Iakovenko, KI | 1 |
Tarusina, TO | 2 |
Kuleshov, NP | 4 |
Lunga, IN | 1 |
Lyon, MF | 1 |
Glenister, PH | 1 |
Renner, HW | 2 |
Semenov, VV | 1 |
Kuzin, SM | 2 |
Viktorov, VV | 1 |
Dzhemilev, ZA | 1 |
Popandopulo, PG | 2 |
Tulina, AN | 3 |
Fingert, HJ | 1 |
Chang, JD | 1 |
Pardee, AB | 1 |
Sato, S | 1 |
Kitajima, H | 1 |
Konishi, S | 1 |
Takizawa, H | 1 |
Inui, N | 1 |
Sarkisian, TF | 1 |
Movsesian, ES | 1 |
Arutiunian, RM | 1 |
Zasukhina, GD | 1 |
Vasil'eva, SV | 1 |
Funes-Cravioto, F | 1 |
Yakovienko, KN | 1 |
Zhurkov, VS | 2 |
Andreesu, M | 1 |
Matefsu, C | 1 |
Mogos, I | 1 |
Mudric, V | 1 |
Dubinina, LG | 2 |
Arutyunyan, RM | 1 |
Funes Cravioto, F | 1 |
Cravioto, FF | 1 |
Korman, NP | 1 |
Azhaev, SA | 2 |
Shevchenko, VV | 1 |
Protopopova, EM | 1 |
Grigor'eva, GA | 1 |
Bolotova, TK | 1 |
Fickers, M | 1 |
Speck, B | 1 |
Voĭtovitskiĭ, VK | 2 |
Edygenova, AK | 2 |
Kabiev, OK | 2 |
Gol'dberg, ED | 1 |
Gol'dberg, DI | 1 |
Golubev, IV | 1 |
Bournique, CP | 1 |
Deysson, G | 1 |
Smirnov, AD | 1 |
2 reviews available for thiotepa and Abnormalities, Autosome
Article | Year |
---|---|
Current topics in the pathology of bladder cancer.
Topics: Carcinoma in Situ; Carcinoma, Transitional Cell; Chromosome Aberrations; Chromosomes, Human, 1-3; Cy | 1983 |
[Chemical mutagenesis patterns in experimental mammals].
Topics: Animals; Bone Marrow; Chromosome Aberrations; DNA Repair; Female; Genes; Genes, Dominant; Genes, Let | 1982 |
1 trial available for thiotepa and Abnormalities, Autosome
Article | Year |
---|---|
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophos | 2002 |
82 other studies available for thiotepa and Abnormalities, Autosome
Article | Year |
---|---|
Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carboplatin; Chromoso | 2010 |
EFFECTS OF IONIZING IRRADIATION AND CHEMOTHERAPEUTIC AGENTS ON HUMAN CHROMOSOMES.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Choriocarcinoma; Chromosome Aberrations; C | 1964 |
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration.
Topics: Animals; Area Under Curve; Azure Stains; Bone Marrow Cells; Chromosome Aberrations; Chromosome Paint | 2005 |
Potentiation by hydroxyurea in G2-prophase of thiotepa- and bleomycin-induced chromosomal aberrations in Chinese hamster cells.
Topics: Animals; Bleomycin; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; Drug Synergism; Hydro | 1981 |
[Changes in the occurrence of cytogenetic effects after mutagenic exposure in vivo].
Topics: Animals; Chromosome Aberrations; Crossing Over, Genetic; Dose-Response Relationship, Drug; Lymphocyt | 1983 |
[Comparison of the levels of chromosome aberration and sister chromatid exchange induced by chemical mutagens in vitro].
Topics: Aziridines; Cells, Cultured; Chromosome Aberrations; Crossing Over, Genetic; Dose-Response Relations | 1983 |
[Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Chromosome Aberrations; | 1983 |
Influence of caffeine and 3-aminobenzamide in G2 on the frequency of chromosomal aberrations induced by thiotepa, mitomycin C and N-methyl-N-nitro-N'-nitrosoguanidine in human lymphocytes.
Topics: Benzamides; Caffeine; Cell Cycle; Cells, Cultured; Chromosome Aberrations; DNA Repair; Drug Synergis | 1984 |
Cytogenetic analysis of human peripheral blood lymphocytes in culture exposed in vitro to styrene and styrene oxide.
Topics: Adult; Cells, Cultured; Chromosome Aberrations; Dose-Response Relationship, Drug; Epoxy Compounds; E | 1984 |
[Effect of thiophosphamide on the frequency of chromosome aberrations in cells heterozygous for ataxia-telangiectasia].
Topics: Ataxia Telangiectasia; Cells, Cultured; Chromosome Aberrations; Heterozygote; Humans; Lymphocytes; T | 1980 |
[Effect of long-term exposure to thiophosphamide on the frequency of chromosome aberrations in Chinese hamster cell cultures].
Topics: Animals; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Dose-Response Relationship | 1980 |
Evaluation of thiotepa for genetic damage in mice.
Topics: Animals; Chromosome Aberrations; Male; Metaphase; Mice; Mutagens; Thiotepa; Translocation, Genetic | 1980 |
[101/H line mice, a possible model of human chromosomal instability diseases].
Topics: Animals; Chromosome Aberrations; Chromosome Disorders; Disease Models, Animal; Female; Fetal Death; | 1981 |
[Spontaneous and induced chromosome aberrations in the bone marrow cells of different strains of mice during aging].
Topics: Aging; Animals; Bone Marrow; Chromosome Aberrations; Gamma Rays; Genotype; Male; Mice; Mice, Inbred | 1981 |
[Influence of selection on the sensitivity of laboratory mice to the cytogenetic effect oof thioTEPA].
Topics: Animals; Chromosome Aberrations; Crosses, Genetic; Genetic Variation; Genotype; Inbreeding; Male; Mi | 1982 |
Dose and concentration dependence of chromosome aberrations in human cells and the combined action of radiation and chemical mutagens.
Topics: Chromosome Aberrations; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gam | 1982 |
[Comparison of the frequency of chromosome aberrations induced by thiophosphamide in rabbit lymphocytes in vitro and in vivo].
Topics: Animals; Chromosome Aberrations; Dose-Response Relationship, Drug; In Vitro Techniques; Lymphocytes; | 1982 |
[Interlineage differences in murine sensitivity to thiotepa: an experiment with recombinant strains].
Topics: Animals; Chromosome Aberrations; Crosses, Genetic; Female; Male; Mice; Mice, Inbred C3H; Mutagens; R | 1995 |
[Antimutagenic properties of Angelica archangelica L].
Topics: Animals; Antimutagenic Agents; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Mice; Micronu | 1995 |
[1,4-dihydroisonicotinic acid (1,4-DHINA) derivatives, inhibitors of chemical mutagenesis].
Topics: Animals; Antimutagenic Agents; Bone Marrow; Cells, Cultured; Chromosome Aberrations; Drosophila mela | 1995 |
[Modeling the periodically-changing predictable response to mutagen exposure in CBA/LacY mice in a successive inbred generations].
Topics: Animals; Benzo(a)pyrene; Chromosome Aberrations; Inbreeding; Mice; Mice, Inbred CBA; Mutagens; Thiot | 2001 |
Ten model mutagens evaluated by the micronucleus test.
Topics: Animals; Bleomycin; Bone Marrow; Bone Marrow Cells; Cell Line; Cell Nucleus; Chromosome Aberrations; | 1976 |
Relationship between acute and chronic exposures in mutagenicity studies in mice.
Topics: Animals; Arsenic; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Cyclophosphamide; Dose-Res | 1976 |
Sister-chromatid exchanges in human lymphocytes exposed during Go to four classes of DNA-damaging chemicals.
Topics: Bleomycin; Cell Cycle; Chlorambucil; Chromatids; Chromosome Aberrations; Cytarabine; DNA; Humans; Ly | 1979 |
Caffeine enhancement of chromosomal aberrations induced by thiotepa in bone marrow cells of mice.
Topics: Animals; Bone Marrow; Caffeine; Chromosome Aberrations; Chromosomes; Drug Synergism; Male; Mice; Thi | 1978 |
[Thiophosphamide-induced chromosome aberrations in embryonal liver and bone marrow cells of A/He and C57BL/L mice].
Topics: Animals; Bone Marrow; Chromosome Aberrations; Embryo, Mammalian; Female; Liver; Male; Mice; Mice, In | 1979 |
Mutagenicity tests with griseofulvin.
Topics: Animals; Bone Marrow; Chromosome Aberrations; Corpus Luteum; Dose-Response Relationship, Drug; Embry | 1979 |
[Estimation of the contribution of thiophosphamide-induced chromosomal aberrations to perimplantation embryonic mortality in mice].
Topics: Animals; Chromosome Aberrations; Embryo, Mammalian; Embryonic Development; Female; Fetal Death; Kary | 1979 |
The apparent decrease in thiotepa-induced chromosome aberrations in human lymphocytes caused by an effect of WR2721 on the cell cycle as found by the definitively determined division method.
Topics: Amifostine; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Chromosomes, Human; Humans; Lymphoc | 1979 |
Enhancement by caffeine of cell killing and chromosome damage in Chinese hamster cells treated with thiotepa.
Topics: Animals; Caffeine; Cell Line; Cell Survival; Chromosome Aberrations; Chromosomes; Clone Cells; Crice | 1977 |
[Genetic control of mutability in laboratory mice. I. Genetic analysis of the sensitivity of mice of strains 101/H and C57BL/6 to the mutagenic effect of thio-TEPA].
Topics: Animals; Bone Marrow; Chromosome Aberrations; Chromosomes; Mice; Mice, Inbred C57BL; Mice, Inbred St | 1977 |
[Analysis of the types of chromosome aberrations in the combined action of chemical mutagens].
Topics: Aziridines; Cells, Cultured; Chromatids; Chromosome Aberrations; Dose-Response Relationship, Drug; D | 1978 |
[Mutagenic effect of chemical compounds on laboratory mice].
Topics: Animals; Chromosome Aberrations; Embryonic Development; Female; Genes, Dominant; Genes, Lethal; Male | 1978 |
Enhancement by methylated oxypurines of the frequency of induced chromosomal aberrations.
Topics: Animals; Caffeine; Cell Line; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cricetinae; Drug | 1975 |
[Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].
Topics: Chromosome Aberrations; Female; Humans; Ovarian Neoplasms; Thiotepa | 1975 |
[Mathematical modeling of the relationship between the cytogenetic effect and the concentration of the mutagen].
Topics: Cells, Cultured; Chromosome Aberrations; Dose-Response Relationship, Drug; Humans; Lymphocytes; Math | 1975 |
[The mutagenic effect of thio-TEPA in laboratory mice. III. A comparison of the effect of different doses in the generative and somatic cells of male mice].
Topics: Aneuploidy; Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Genes, Dominant; Genes, | 1975 |
[The relationship between the cytogenetic action of thiophosphamide and the duration of human cell treatment].
Topics: Chromatids; Chromosome Aberrations; Chromosomes; Humans; Lymphocytes; Mutagens; Thiotepa; Time Facto | 1975 |
[The mutagenic effect of thioTEPA in laboratory mice. IV. The influence of genotype and sex on the frequency of induced chromosome aberrations in bone marrow cells].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Female; Genotype; Male; Mice; Mice, Inbred AKR; | 1975 |
[The mutagenic effect of thioTEPA in laboratory mice. V. The influence of female genotype on the realization of dominant lethal mutations induced in male spermatids].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Female; Genes, Dominant; Genes, Let | 1975 |
[Cytological study of early embryonic mortality in laboratory mice].
Topics: Animals; Animals, Laboratory; Chromosome Aberrations; Embryo Loss; Embryonic Development; Female; Fe | 1975 |
Enhancement by methylated oxypurines of the frequency of induced chromosomal aberrations. IV. The dependence of the potentiation on the type of material.
Topics: Caffeine; Cell Line; Chromosome Aberrations; Drug Synergism; Maleic Hydrazide; Mitomycins; Plants; T | 1976 |
[Mutation process in man].
Topics: Chromosome Aberrations; Chromosomes; Genetic Diseases, Inborn; Humans; Mutagens; Mutation; Thiotepa | 1976 |
[Individual variations in the frequency of chromosome aberrations following exposure to chemical mutagens. II. Interindividual variation in the frequency of chromosome aberrations in the presence of different mutagen concentrations].
Topics: Chromosome Aberrations; Chromosomes; Dose-Response Relationship, Drug; Genetic Variation; Humans; Mu | 1976 |
[Individual variations in the frequency of chromosome aberrations following exposure to chemical mutagens. III. Interindividual differences at different stages of the cell cycle].
Topics: Aziridines; Azirines; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cytarabine; Genetic Vari | 1976 |
[Cytogenetic damage and the degree of reparative synthesis in the lymphocytes of chemical industry workers].
Topics: Adult; Air Pollutants, Occupational; Cells, Cultured; Chemical Industry; Chromosome Aberrations; Cul | 1991 |
A search for strain differences in response of mice to mutagenesis by thio-TEPA.
Topics: Animals; Bone Marrow; Chromosome Aberrations; Genes, Dominant; Genes, Lethal; Injections, Intraperit | 1991 |
In vivo effects of single or combined dietary antimutagens on mutagen-induced chromosomal aberrations.
Topics: Animals; beta Carotene; Carotenoids; Chlorophyll; Chlorophyllides; Chromosome Aberrations; Cricetina | 1990 |
[Mutagenic activity of antineoplastic agents under conditions of normal and artificial modification].
Topics: Antineoplastic Agents; Aziridines; Chromosome Aberrations; Interphase; Melphalan; Mutagens; Plants; | 1990 |
[The induction and elimination of cytogenetic disorders in monkey lymphocytes following thiophosphamide action].
Topics: Animals; Cells, Cultured; Chromosome Aberrations; Lymphocytes; Macaca mulatta; Male; Mathematics; Mo | 1989 |
[Interchangeability of mutagens during fractionated effects of unequal concentrations of alkylating agents].
Topics: Alkylating Agents; Aziridines; Cells, Cultured; Chromatids; Chromosome Aberrations; Humans; Lymphocy | 1989 |
[Effects of exposure time using preliminary concentrations on the mutagenic effect of the basic action of one-center and dual-center mutagens].
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Cells, Cultured; Chromosome Aberrations; Cultu | 1989 |
[The effect of fractionated exposure to unequal concentrations of chemical mutagens].
Topics: Aziridines; Cells, Cultured; Chromosome Aberrations; Dose-Response Relationship, Drug; Humans; Lymph | 1989 |
Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
Topics: Alkylating Agents; Caffeine; Cell Cycle; Cell Line; Cell Survival; Chromosome Aberrations; Chromosom | 1986 |
[Quantitative comparison of the cytogenetic effect of thiophosphamide during in vivo and in vitro action on monkey lymphocytes].
Topics: Animals; Chromosome Aberrations; Dose-Response Relationship, Drug; In Vitro Techniques; Lymphocytes; | 1987 |
Mouse strain differences in the induction of micronuclei by polycyclic aromatic hydrocarbons.
Topics: Animals; Biotransformation; Bone Marrow; Cell Nucleus; Chromosome Aberrations; Cyclophosphamide; Mic | 1987 |
[Thiophosphamide induction of chromosome disorders in the spermatogonia of 101/HY, TPS/Y and CBA/LacY inbred mouse strains].
Topics: Animals; Bone Marrow; Chromosome Aberrations; Chromosomes; Diploidy; Dose-Response Relationship, Dru | 1988 |
[Dynamics of the frequencies of sister chromatid exchange and chromosome aberrations in vivo].
Topics: Animals; Chromosome Aberrations; Dose-Response Relationship, Drug; Metaphase; Mutagenicity Tests; Ra | 1988 |
[Effect of interferon on the number of cytogenetic disorders occurring in human cultured lymphocytes treated with thio-TEPA and fotrin].
Topics: Aziridines; Azirines; Cells, Cultured; Chromosome Aberrations; Drug Interactions; Humans; Interferon | 1988 |
[Modification of the genetic effect of N-nitrosoethylurea in inbred mice by para-aminobenzoic acid].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Animals; Bone Marrow; Chromosome Aberrations; Drug Interactions | 1985 |
Anticlastogenic effect of beta-carotene in Chinese hamsters. Time and dose response studies with different mutagens.
Topics: Alkylating Agents; Animals; beta Carotene; Bone Marrow Cells; Busulfan; Carotenoids; Chromosome Aber | 1985 |
[Problems of mutagenesis in man].
Topics: Adult; Age Factors; Chromosome Aberrations; Fetus; Genetics, Medical; Humans; Infant, Newborn; Infan | 1973 |
Localization of chemically induced breaks in chromosomes of human leucocytes.
Topics: Cells, Cultured; Chromosome Aberrations; Chromosome Mapping; Chromosomes; Female; Humans; In Vitro T | 1974 |
[Chromosomal studies in correlation with other biologic constants in neoplasms treated by chemotherapy].
Topics: Adult; Antibody Formation; Bone Marrow; Cell Division; Chromosome Aberrations; Female; Fluorouracil; | 1974 |
[Chromosome mutations in human leukocytes and the test-system problem in the analysis of the mutagenicity of biosphere factors].
Topics: Autoradiography; Chromosome Aberrations; Chromosomes; Humans; In Vitro Techniques; Leukocytes; Mitos | 1974 |
Modifying effect of cysteine on the induction of chromosomal aberrations by thioTEP in a culture of human leukocytes.
Topics: Cells, Cultured; Chromosome Aberrations; Cysteine; Humans; In Vitro Techniques; Leukocytes; Mutagens | 1974 |
Localization of breaks in human chromosomes induced by thio-TEPA in peripheral blood lymphocyte cultures at different times.
Topics: Cells, Cultured; Chromosome Aberrations; Chromosome Mapping; Chromosomes; Humans; In Vitro Technique | 1974 |
Intensity of chemical mutagenesis in human cells as a function of age and sex.
Topics: Adult; Age Factors; Aged; Cells, Cultured; Chromatids; Chromosome Aberrations; Chromosomes, Human, 1 | 1973 |
Distribution of defective chromosomes in human cells after treatment with chemical mutagens in vitro and in vivo.
Topics: Cells, Cultured; Chromatids; Chromosome Aberrations; Chromosomes; Dose-Response Relationship, Drug; | 1974 |
[Mutagenic effect of thio-TEPA in laboratory mice. I. Chromosome aberrations in somatic and germ cells of male mice].
Topics: Aneuploidy; Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Genes, Dominant; Genes, | 1974 |
[Mutagenic effect of thio-TEPA in laboratory mice. II. Cytogenetic analysis of damage to bone marrow cells].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Dose-Response Relationship, Drug; M | 1974 |
[Analysis of somatic cell chromosomes in patients treated with antineoplastic agents].
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Cyclopho | 1973 |
[Cytogenetic effect of ethylenimine derivatives in cultures of human lymphocytes. I. Experimental findings and mathematical verification of quantitative patterns].
Topics: Aziridines; Azirines; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cyclic P-Oxides; Dimetho | 1974 |
[Prolonged mutagenesis in a culture of human leukocytes].
Topics: Aziridines; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cyclic P-Oxides; DNA; Drug Interac | 1974 |
[Cytogenetic effect of ethylenimine derivatives in human lymphocyte cultures. III. An analysis of the types of chromosome aberrations].
Topics: Aziridines; Azirines; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cyclic P-Oxides; Humans; | 1974 |
Change in the activity of chemical mutagens during their interaction with seed metabolites.
Topics: Chromosome Aberrations; Dimethoate; Ethylenes; Hydrazines; Imines; Maleates; Mechlorethamine; Mesyla | 1971 |
Thrombocythaemia. Familial occurrence and transition into blastic crisis.
Topics: Alkaline Phosphatase; Anemia, Aplastic; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; | 1974 |
[Chromosome characteristics of tumors during changes in drug resistance (experimental study)].
Topics: Animals; Antineoplastic Agents; Cell Line; Chromosome Aberrations; Drug Resistance; Female; Melphala | 1973 |
[Disturbances of mitotic activity in hemohistoblasts of the bone marrow during acute radiation injury and under the effects of chemical mutagenic agents].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Nucleus; Chromosome Aberrations; Cyclop | 1967 |
[Distribution of chromosomal fragments induced by methoxy-9 ellipticin lactate in human diploid cells cultivated in vitro].
Topics: Alkaloids; Chromosome Aberrations; Chromosomes; Culture Techniques; Diploidy; Fibroblasts; Humans; L | 1971 |
[Modifying effect of cystamine in some mutagenic influences on the human organism].
Topics: Bone Marrow; Bone Marrow Cells; Bronchial Neoplasms; Chromosome Aberrations; Cystamine; Humans; Male | 1971 |
[Chromosome aberrations in cells of a thiophosphamide-resistant tumor arising during a single treatment with alkylating preparations and x-rays].
Topics: Animals; Cell Line; Chromosome Aberrations; Culture Techniques; Female; Melphalan; Neoplasms, Experi | 1971 |